Vendor, Durham, NC
Gradient Health, Inc.
UEI JXJ9QTSG87C5, CAGE 89XE3
1 award and $388,108 obligated between September 4, 2024 and November 26, 2024, 100% under full and open competition, against 5.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $388,108 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91024C00061Definitive Contract, September 4, 2024, Full and Open Competition After Exclusion of Sources, 5 offers | NIH NCINational Institutes of Health | Advancing Equity and Diversity in Breast Cancer Screening: Creating a Foundational Dataset and Toolset.NAICS 541714, PSC AN12 | $388,108 |
- Places of performance
- North Carolina
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 4 across 1 awards